ASCO GU 2023: Outcomes of patients with kidney cancer brain metastases treated with first-line therapies
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Previously, researchers found some genes that helped identify which patients [...]
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
The Scottish Medicines Consortium (SMC) has approved the use of [...]
Combinations of immunotherapy and vascular endothelial growth factor (VEGF) inhibitors [...]
The cabozantinib/nivolumab combination has been shown to be effective at [...]
Despite the advances in first-line treatments for metastatic renal cell [...]
The increase in the number of first-line treatments for metastatic [...]
The use of combination therapies for the first-line treatment of [...]